Zak Mir delivers a charting take on some of the most followed stocks on the London market. Today’s selection includes African, Ferro, Hemo, i3, ImmuPharma, Nanosynth, Rua, THG, United Oil
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 9th November 2021 via Vox Markets
Zak Mir takes a look at some of the most followed small caps on the London market. Today’s selection includes Alpha Growth, Bens Creek Group, Feedback, Gunsynd, ImmuPharma, Powerhouse, Rambler
Share Talk Bulletin Board Heroes, Thursday 14th May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Wednesday 15th April 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Thursday 28th November 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Immupharma PLC (LON:IMM) Licence Agreement for Lupuzor with Avion in US
ImmuPharma and Avion Pharmaceuticals sign exclusive licence and development agreement and trademark agreement for Lupuzor™ with Avion to fund new international Phase III trial and commercialise in the US
Tim McCarthy , Non-Executive Chairman of ImmuPharma (AIM:IMM) Interview
ImmuPharma focuses on developing pioneering and novel drugs in specialist therapeutic areas
Share Talk Bulletin Board Heroes: 21st June 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers
Share Talk Bulletin Board Heroes: 24th May 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers #EDRÂ Egdon Resources PLC #FRR Frontera Resources PLCÂ #IMMÂ Immupharma PLC #MOS Mobile Streams PLCÂ #PMGÂ Parkmead
Shard Capital: Insights into the small pharmaceutical company sector (video)
Wealth Manager at Shard Capital Stockbrokers, Simon Niven, provides some insights into the small pharmaceutical company sector.